Antibodies and reagents. 9336) and antibodies were purchased from Cell Signaling Technology. Anti-pERK1/2 (SC-7383) and ERK1/2 (SC-94) antibodies were purchased from Santa Cruz Biotechnology.
Supplementary Method
Antibodies and reagents. Anti-pGSK-3 (Ser9, 9336) and GSK-3 (9315) antibodies were purchased from Cell Signaling Technology. Anti-pERK1/2 (SC-7383) and ERK1/2 (SC-94) antibodies were purchased from Santa Cruz Biotechnology.
The mouse p62/SQSTM1 specific predesigned siRNA (6399) was purchased from Cell Signaling Technology. The mouse NDP52 specific siRNA (141979) was purchased from Santa Cruz Biotechnology.
MTT assay. Cell viability was assessed by using thiazolyl blue tetrazolium bromide 
